UMB Data Catalog

A project of the Health Sciences and Human Services Library

Filter by

of 1 Next >
Results Found: 3

  • GISAID

    Alternate Title(s)
    Global Initiative on Sharing All Influenza Data
    Description

    "The GISAID Initiative promotes the rapid sharing of data from all influenza viruses and the coronavirus causing COVID-19. This includes genetic sequence and related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses, to help researchers understand how viruses evolve and spread during epidemics...

    Subject
    COVID-19
    Influenza in Birds
    Influenza, Human
    Access Rights
    Unrestricted access
    Local Experts
    Davide Zella
    Francesca Benedetti
    Robert C. Gallo
  • UMB Dataset

    mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

    Authors
    Etsuro Nanishi
    Marisa E. McGrath
    Timothy R. O’Meara
    Soumik Barman
    17 more author(s)...
    Description

    This study investigates multiple vaccine strategies to enhance immunogenicity and protection against SARS-CoV-2 in aged mice. The study aims to determine the effect of a booster dose, with an emphasis on older age. Female three and eleven-month-old BALB/c mice were studied over the course of 38 weeks. Mice received BNT162b2 SARS-CoV-2 spike mRNA vaccine series, primary vaccination series, and mock...

    Subject
    COVID-19/prevention & control
    Viral Vaccines/genetics
    Access Rights
    Unrestricted access
    Local Experts
    Matthew B. Frieman
  • UMB Dataset

    Kinetics of SARS-CoV-2 antibody responses preCOVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case–control study

    Authors
    Magali J. Fontaine
    Matthew N. Klein
    Elizabeth Wenqian Wang
    Paul Zimand
    8 more author(s)...
    Description

    This observational retrospective control study investigated the development of the humoral immune response to SARS-CoV-2 in convalescent plasma (CCP) recipients (n=34) and compared it to the humoral response in a group of patients not treated with CCP (n=68). Additionally, a separate comparison of clinical outcomes was performed between CCP recipients and a matched control group of untreated patients...

    Subject
    COVID-19
    Immunization, Passive
    Timeframe
    2020
    Access Rights
    Approval required